Direct detection of infectious human immunodeficiency virus type 1 (HIV-1) immune complexes in the sera of HIV-1-infected persons
| dc.contributor.author | Kobayashi, Koichi S. | |
| dc.contributor.author | Takeda, Akira | |
| dc.contributor.author | Green, Sharone | |
| dc.contributor.author | Tuazon, Carmelita U. | |
| dc.contributor.author | Ennis, Francis A. | |
| dc.date | 2022-08-11T08:09:10.000 | |
| dc.date.accessioned | 2022-08-23T16:19:42Z | |
| dc.date.available | 2022-08-23T16:19:42Z | |
| dc.date.issued | 1993-09-01 | |
| dc.date.submitted | 2017-11-13 | |
| dc.identifier.citation | J Infect Dis. 1993 Sep;168(3):729-32. | |
| dc.identifier.issn | 0022-1899 (Linking) | |
| dc.identifier.pmid | 8354914 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.14038/35113 | |
| dc.description.abstract | The sera of human immunodeficiency virus type 1 (HIV-1)-infected subjects were examined for the presence of infectious HIV-1-antibody complexes by their ability to infect Fc gamma receptor (Fc gamma R)-bearing cells. Infection of Fc gamma R-bearing cells by a serum in which half of the p24 antigen was present in a form of immune complexes was inhibited by aggregated human immunoglobulin. Then in studies on 22 sera, 9 sera produced p24 antigen during 14 days of culture in U937 cells. HIV-1 p24 production was inhibited or delayed by the pretreatment of cells with aggregated human immunoglobulin in 6 of the 9 sera that were infectious. These results may reflect interactions between virus-antibody complexes and Fc gamma R-bearing cells in vivo because serum itself was used as the source of virus and virus-antibody complexes. The results indicate that infectious HIV-1 immune complexes are present in the circulation of HIV-1-infected patients. | |
| dc.language.iso | en_US | |
| dc.relation | <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=8354914&dopt=Abstract">Link to Article in PubMed</a> | |
| dc.relation.url | http://www.jstor.org/stable/30113442 | |
| dc.subject | Immunity | |
| dc.subject | Immunology and Infectious Disease | |
| dc.subject | Immunology of Infectious Disease | |
| dc.subject | Infectious Disease | |
| dc.subject | Virology | |
| dc.title | Direct detection of infectious human immunodeficiency virus type 1 (HIV-1) immune complexes in the sera of HIV-1-infected persons | |
| dc.type | Journal Article | |
| dc.source.journaltitle | The Journal of infectious diseases | |
| dc.source.volume | 168 | |
| dc.source.issue | 3 | |
| dc.identifier.legacycoverpage | https://escholarship.umassmed.edu/infdis_pp/322 | |
| dc.identifier.contextkey | 11035661 | |
| html.description.abstract | <p>The sera of human immunodeficiency virus type 1 (HIV-1)-infected subjects were examined for the presence of infectious HIV-1-antibody complexes by their ability to infect Fc gamma receptor (Fc gamma R)-bearing cells. Infection of Fc gamma R-bearing cells by a serum in which half of the p24 antigen was present in a form of immune complexes was inhibited by aggregated human immunoglobulin. Then in studies on 22 sera, 9 sera produced p24 antigen during 14 days of culture in U937 cells. HIV-1 p24 production was inhibited or delayed by the pretreatment of cells with aggregated human immunoglobulin in 6 of the 9 sera that were infectious. These results may reflect interactions between virus-antibody complexes and Fc gamma R-bearing cells in vivo because serum itself was used as the source of virus and virus-antibody complexes. The results indicate that infectious HIV-1 immune complexes are present in the circulation of HIV-1-infected patients.</p> | |
| dc.identifier.submissionpath | infdis_pp/322 | |
| dc.contributor.department | Department of Medicine, Division of Infectious Diseases and Immunology | |
| dc.contributor.department | Center for Infectious Disease and Vaccine Research | |
| dc.source.pages | 729-32 |